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Abstract: The present work examines the potential of sesquiterpenoids to sensitize Escherichia coli and Staphylococcus 
aureus, and modulate their susceptibility to the standard antibiotics ciprofloxacin, erythromycin, gentamicin and vanco-
mycin. It was tested samples of three sesquiterpenoids: guaiazulene, nerolidol (racemic mixture of the cis and trans iso-
mers) and germacrene D enriched natural extract. Experiments were conducted aiming to assess the antimicrobial effects 
of the antibiotic-sesquiterpenoid combination on bacterial growth inhibition, by the disc diffusion assay and the minimum 
inhibitory concentration (MIC) assessment, the bactericidal effects, the post-antibiotic effect (PAE) and the effect on 
membrane permeability. The data related with the antimicrobial activity evidenced, through the disc diffusion assay, an 
antibiotic S. aureus antimicrobial activity enhancement by sesquiterpenoids presence. The MIC value for E. coli decreased 
significantly by sesquiterpenoids combination with ciprofloxacin, erythromycin and gentamicin, and for S. aureus, with 
all four selected antibiotics. This combination also increased the PAE, with the exception of guaiazulene, which seemed to 
quench antibiotic antimicrobial action. A moderate correlation between antimicrobial action and impairment of cell mem-
brane function was detected for germacrene D enriched extract, and nerolidol, as single treatments and in combination 
with antibiotic, while a poor correlation was obtained for guaiazulene.  
This study provides basis for the evaluation of sesquiterpenoids as alternative or possible synergistic compounds for cur-
rent antimicrobial chemotherapeutics, showing the practical utility of natural derived products to increase the susceptibil-
ity of E. coli and S. aureus.
Key Words: Antibacterial drug screening, antibiotics, antimicrobial action, mechanisms of action, natural products, post-
antibiotic effect, resistance, sesquiterpenoids. 
INTRODUCTION 
 To survive in the environment, bacteria must respond to 
several stresses that lead to non-ideal growth conditions. As 
an additional stress, they may be exposed to a wide range of 
antimicrobial agents, such as antibiotics, that can act as a 
selective pressure for the development of resistant microor-
ganisms [1]. As a result of antibiotic use and misuse, increas-
ing incidence of resistance to antimicrobials is a growing 
concern of the medical, food and sanitation areas [2-6].
Reduced susceptibility of microorganisms to antimicrobial 
agents may be acquired through mutation, by plasmid or 
transposon acquisition, or by the microorganisms intrinsic 
properties conferring reduced susceptibility to antimicrobial 
agents [3,7-10]. To counter the increasing emergence of re-
sistant microorganisms, substantial resources have been in-
vested in the research of new antimicrobial compounds, 
mainly of microbial and plant origin [11-13]. 
 A wide variety of essential oils derived from plants are 
known to have antimicrobial properties which, in many 
cases, are due to the presence of active terpene constituents  
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[12]. These oils are secondary metabolites highly enriched of 
compounds based on an isoprene (C5 chain) structure [14]. 
Sesquiterpenoids (C15 chain), formed by the assembly of 
three isoprenoid units synthesized from acetate units, share 
their origins with fatty acids, and are known to have antimi-
crobial activity [11,14,15]. 
 Terpenoids and other essential oils constituents occur 
widely in nature contributing to characteristic plants and 
products flavours and aromas [11]. Their mechanism of anti-
bacterial action is yet not fully understood, but it is specu-
lated to involve membrane disruption through lipophilic 
compounds [11,14, 16]. According to a previous study [16], 
this action results in membrane expansion, increase of mem-
brane fluidity and permeability, disturbance of membrane 
embedded proteins, inhibition of respiration, and alteration 
of ion transport processes. This action can contribute to the 
decrease of microbial resistance and avoid the spread of re-
sistant strains [6,17]. 
 In this study, we report the antimicrobial and sensitizing 
actions of three selected samples of sesquiterpenoids, pre-
senting different structural features (Fig. 1), against two 
clinically significant microorganisms, E. coli and S. aureus.
These actions were assessed through the combination of an-
tibiotics and sesquiterpenoids on bacterial growth inhibitory 
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and bactericidal effects, post-antibiotic effect, and effect on 
the membrane permeability. 
MATERIALS AND METHODS 
Bacterial Strains and Culture Conditions 
 The bacterial strains used were Escherichia coli (ATCC 
25922) and Staphylococcus aureus (ATCC 25923). Mueller-
Hinton broth (Merck, Portugal) was used to culture both bac-
teria, at 37 ºC. 
Sesquiterpenoids and Antibiotics 
 Three samples of sesquiterpenoids were used: guai-
azulene- GU (> 98 %, TCI Europe, Zwijndrecht, Belgium), 
nerolidol- NL (> 98 %, racemic mixture of the cis and trans
isomers, Aldrich, Madrid, Spain) and germacrene D- GE (40 
%, natural extract enriched in germacrene D, this extract also 
contains other sesquiterpenoids, -farnesene (ca. 10 %) is 
the second most abundant, R. C. Treatt & CO, LTD, Suffolk, 
United Kingdom). These samples were tested at 20 mM for 
every experiment. Ciprofloxacin (CIP), erythromycin (ERY), 
gentamicin (GEN) and vancomycin (VAN) were obtained 
from Sigma (Portugal) and paper discs, containing known 
quantities of the same antibiotics, were obtained from Quila-
ban (Portugal). 
Antibiotic Disk Assay 
 Cells from an overnight growth culture (log phase cul-
tures) were suspended in 0.5 mL of phosphate (KH2PO4;
Na2HPO4) buffer (2 mM, pH 7) and mixed with 5 mL (0.7% 
w/v) of Mueller-Hinton agar (Oxoid, England), tempered at 
45 ºC. Sesquiterpenoids dissolved in ethanol (0.5 % v/v) 
were added to the cell/Mueller-Hinton broth mixture yielding 
final concentrations of 20 mM. The final cell concentration 
was approximately 108 CFU/mL. The vortexed (Heidolph, 
model Reax top – 50 % of maximum power input) mixtures 
were poured over hardened Mueller-Hinton agar (1.5 % w/v) 
plates using a sterilized cotton swab and allowed to set. An-
tibiotic discs containing CIP (5 g/disc), ERY (15 g/disc), 
GEN (10 g/disc) and VAN (30 g/disc) were placed on the 
surface of plates containing sesquiterpenoids and bacteria. 
After a 37 ºC, 24 h incubation period, zones of growth inhi-
bition were measured, according to the CSLI/NCCLS stan-
dard [18]. The experiments were repeated at three different 
occasions for every scenario tested.  
Minimum Inhibitory Concentration  
 The minimum inhibitory concentration (MIC) was de-
termined as the lowest concentration of antibiotic where no 
growth was detected by the standard CSLI/NCCLS broth 
microdilution method [19]. A constant concentration of 20 
mM of each sesquiterpenoid, with a varying antibiotic con-
centration, was used for MIC determination. The experi-
ments were repeated at three different occasions for every 
condition tested.  
Post-antibiotic Effect - Determination of Lag of Re-
growth 
 Post-antibiotic effect (PAE) experiments were carried out 
at 37 °C through the determination of the lag of regrowth. 
Log phase cultures of approximately 108 CFU/mL were 
mixed in glass tubes, in a total phosphate buffer volume of 2 
mL, mixed with the different sesquiterpenoids at the desired 
concentration or with a sesquiterpenoid free control. A 1/5 
MIC concentration of CIP was applied to bacteria in order to 
allow a lag evaluation, not possible when using a MIC. After 
incubation at 37 °C and 120 rpm, for 30 min, the action of 
sesquiterpenoids, CIP, and the combination of sesquiterpe-
noids with antibiotic was terminated by a dilution procedure. 
Aliquots of 100 L were removed from each culture and 
diluted in 900 L pre-warmed (37 °C) 2 mM phosphate 
buffer. After mixing and incubation for 2 - 3 min, 200 L of 
each suspension was mixed with 1800 L pre-warmed Muel-
ler-Hinton broth and incubated at 37 °C. The resulting re-
growth curve was constructed by viable counts at the time of 
antimicrobial inactivation (dilution to sub-inhibitory concen-
trations) and at appropriate intervals thereafter (up to 8 h). 
Aliquots were removed from all cultures, serially diluted in 2 
mM phosphate buffer, and plated as 10 L spots in triplicate 
on Mueller-Hinton agar plates (undiluted suspensions were 
plated with 100 L). After incubation for 18 - 24 h at 37 °C, 
CFU were counted. Lag of regrowth duration was calculated 
by means of the equation lag (time) = T - C, where T is the 
time required for the CFU count in the test culture to in-
crease by 1log10, immediately after the dilution procedure, 
and C is the time required for the CFU count in an untreated 
culture to increase by 1log10 above the count observed after 
chemical removal. A significant lag of regrowth was defined 
as a lag  0.5 h [20]. The experiments were repeated at three 
different occasions for every condition tested.  
Time-kill Curves  
 Time-kill curves were performed with CIP at 1/5 MIC 
and/or sesquiterpenoids (20 mM) in Mueller-Hinton broth at 
37 °C, in a total volume of 3 mL. An inoculum of 1  108
CFU/mL of S. aureus and E. coli, in the log phase of growth, 
was used. Samples were taken at 0, 30, 60, 90 and 120 min 
after inoculum addition. The number of bacteria in the sam-
ples was determined by making serial dilutions in 2 mM 
Fig. (1). Chemical structure of germacrene D (a), guaiazulene (b), and trans- and cis-nerolidol. 
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phosphate buffer. Thirty L of each dilution were plated on
Mueller-Hinton agar plates and incubated overnight, at 37 
°C. Colonies were counted after 18-24 h incubation period. 
Each curve was determined in triplicate. 
Assessment of Membrane Integrity - Propidium Iodide 
Uptake 
 The Live/Dead BacLightTM kit (Molecular Probes, L-
7012, Leiden, Netherlands) assesses membrane integrity by 
selective stain exclusion [21]. The BacLightTM kit is com-
posed of two nucleic acid-binding stains: SYTO 9TM and 
propidium iodide (PI). SYTO 9TM penetrates all bacterial 
membranes and stains the cells green, while PI only pene-
trates cells with damaged membranes, and the combination 
of the two stains produces red fluorescing cells. After bacte-
rial exposure to the antimicrobial treatment (single applica-
tion of CIP, sesquiterpenoids, and a combination of CIP/ses-
quiterpenoids) for a period of 30 min, the various bacterial 
suspensions (1  108 CFU/mL) were diluted 1:10 and 300 L
of each diluted suspension were filtered through a Nucleo-
pore® (Whatman) black polycarbonate membrane (pore size 
0.22 m) and stained with 250 L diluted (1:250) SYTO 9 
and 250 L diluted (1:250) PI for 15 min in the dark at 37 ±
1 ºC, according to the manufactures protocol. To observe the 
stained bacteria, a Zeiss (AXIOSKOP) microscope fitted 
with fluorescence illumination was used with a 100 oil im-
mersion fluorescence objective. The optical filter combina-
tion for optimal viewing of stained preparations consisted of 
a 480 to 500 nm excitation filter in combination with a 485 
nm emission filter. Several microphotographs of the stained 
bacterial samples were obtained using a microscope camera 
(AxioCam HRC, Carl Zeiss), and a program path (AxioVi-
sion, Carl Zeiss Vision) involving image acquisition and 
processing. A program path (Sigma Scan Pro 5), for object 
measurement and data output, was used to obtain the total 
cells number (both stains) and the number of PI stained cells. 
The total cells number and the number of PI stained cells, on 
each polycarbonate membrane, was estimated from counts of 
a minimum of 20 fields of view. The range of cell counts for 
each field was between 50-200 cells/field. The experiments 
were repeated at three different occasions for every condition 
tested.  
Statistical Analysis 
 The data were analysed using the statistical program 
SPSS version 14.0 (Statistical Package for the Social Sci-
ences). The mean and standard deviation within samples 
were calculated for all cases. Paired t-test analyses were per-
formed for data assuming a normal distribution. The other 
data were statistically analyzed by the nonparametric Wil-
coxon test. Statistical calculations were based on confidence 
level equal or higher than 95% (P < 0.05 was considered 
statistically significant). 
RESULTS 
Antibiotic Disc Diffusion Assay – Sesquiterpenoids Ac-
tion 
 As measured by antibiotic disc diffusion assay (Table 1), 
an increase in antimicrobial activity, promoted by the com-
bination of antibiotics and sesquiterpenoids, was only found 
for S. aureus. Furthermore, it was only found for particular 
combinations: CIP/GU; CIP/NL; ERY/GE; ERY/GU; GEN/ 
GU; GEN/NL; VAN/GE; VAN/GU; VAN/NL. A remarked 
S. aureus growth inhibition was promoted by the combina-
tion of CIP with NL, and VAN with all three sesquiterpe-
noids (P < 0.05). Experiments with E. coli showed no sig-
nificant growth inhibition enhancement by sesquiterpenoids, 
when comparing with single exposure to antibiotics (P > 
0.05). 
Minimum Inhibitory Concentration 
 A growth inhibitory effect was found with the presence 
of antibiotics against both bacteria (Table 2). The combina-
tion of sesquiterpenoids and antibiotics decreased the MIC of 
CIP, ERY and GEN against E. coli, and decreased the VAN 
antimicrobial effects. In fact, VAN is known to inhibit cell 
wall synthesis, being ineffective against Gram-negative bac-
teria. For S. aureus, except for VAN with GE, the combina-
tion of antibiotics with the tested sesquiterpenoids decreased 
the MIC value of those antibiotics.  
PAE after Exposure to Sesquiterpenoids and a sub-MIC 
of CIP  
 An important feature involved in antibiotics activity is 
the post-antibiotic effect (PAE) or lag of bacterial regrowth, 
following a short bacterial exposure to an antimicrobial 
agent. Such data may contribute to the choice of the most 
suitable antimicrobial agent, as an extended lag will induce 
an antibacterial effect longer than expected from the contact 
time. CIP was selected for PAE (Table 3), time-kill (Fig. 2)
Table 1. Antimicrobial Activity Against E. coli and S. aureus Observed by Disc Diffusion Assay. The Means ± SD for at Least 
Three Replicates are Illustrated. GE - Germacrene D; GU - Guaiazulene; NL - Nerolidol 
Diameter of Zone of Inhibition (mm) 
E. coli S. aureus 
Control GE GU NL Control GE GU NL 
Ciprofloxacin (CIP) 36.0 ± 0.0 29.0 ± 1.4 31.5 ± 1.0 31.5 ± 1.0 24.0 ± 0.0 22.5 ± 2.1 33.5 ± 1.0 45.0 ± 4.2 
Erythromycin (ERY) 11.0 ± 1.4 9.50 ± 1.0 8.00 ± 0.0 12.0 ± 0.0 11.0 ± 0.0 14.5 ± 1.0 15.0 ± 4.2 11.5 ± 1.0 
Gentamicin (GEN) 22.5 ± 3.5 18.5 ± 1.0 19.0 ± 0.0 20.0 ± 0.0 21.5 ± 1.0 18.5 ± 1.0 27.0 ± 2.8 28.0 ± 1.4 
Vancomycin (VAN) 1.00 ± 0.5 2.50 ± 1.0 3.00 ± 0.0 1.50 ± 1.0 5.00 ± 1.0 18.5 ± 1.0 11.0 ± 0.0 9.50 ± 3.5 
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and PI (Fig. 3) studies due to its effects on cellular suscepti-
bility observed by the MIC values (Table 2), in the absence 
and in combination with sesquiterpenoids. In all situations, a 
decrease in the MIC value was registered when both bacteria 
were exposed to both CIP and sesquiterpenoids.  
 Single application of GE and NL increased the E. coli lag 
of regrowth, i.e., the time to repair sub-lethal injuries, while 
GU had no effect (Table 3). Concerning S. aureus, GE and 
GU did not promote a lag of regrowth, nevertheless, the ap-
plication of 20 mM NL originated one higher than 7 h. In 
fact, this lag (> 7 h) was actually significantly higher than 
the one promoted by CIP (0.15 h) alone. The combined 
treatment increased the lag of regrowth of both bacteria, in 
all situations, except for S. aureus when exposed to CIP and 
GU. Such exposure had a reverse effect, inducing the growth 
ability of S. aureus (PAE = -1.3 h). 
Sub-MIC CIP/Sesquiterpenoids Post-exposure Bacterial 
Counts and Membrane Permeability 
 The combinatory effects of sub-inhibitory CIP (1/5 MIC) 
and sesquiterpenoids concentrations were also assessed by 
means of time-kill assays (Fig. 2). Control tests were con-
ducted by assessment of bacterial culturability along time, in 
chemicals absence (results not shown), showing that the 
number of CFU remained unchanged during the 2 h (P > 
0.05). Exposure to CIP decreased, along time, the number of 
cultivable S. aureus corresponding to a 0.5 log CFU/mL (P < 
0.05). The CIP antimicrobial effect was not detected for E. 
coli (P > 0.05). GE decreased the number of CFU, a phe-
nomenon more significant for S. aureus (P < 0.05) than for 
E. coli (P > 0.05). However, in combination with CIP such 
effect was attenuated for both bacteria (Fig. 2b).  
 Fig. (2c) shows that 20 mM of GU was not efficient in 
decreasing total counts of both bacteria (P > 0.05). For S. 
aureus, the presence of GU even increased the cellular growth 
potential, as the number of cells increased along time (higher 
than 1 log CFU), in comparison to chemical-free experiments. 
This effect was more pronounced at the 60 (S. aureus ex-
posed to GU) and 90 min (S. aureus exposed to CIP and GU) 
sampling times.  
Table 2. Susceptibility of E. coli and S. aureus to Antibiotics by the Microdilution Method. GE - Germacrene D; GU - Guai-
azulene; NL - Nerolidol 
MIC (6g/mL) 
E. coli S. aureus 
Con-
trol 
GE GU NL 
Con-
trol 
GE GU NL 
Ciproflox-
acin (CIP) 
0.01 0.007<MIC<0.01 0.007<MIC<0.01 0.007<MIC<0.01 0.3 0.22<MIC<0.3 0.15 0.15 
Erythromy-
cin (ERY) 
60 3<MIC<4.5 30<MIC<45 30 0.24 0.12 0.12 0.12 
Gentamicin 
(GEN) 
6 0.3<MIC<0.5 0.3<MIC<0.5 0.4 0.45 0.22<MIC<0.3 0.2 0.2 
Vancomycin 
(VAN) 
280 > 280 > 28 > 280 0.35 > 0.35 
0.26<MIC<0.3
5
0.175 
Table 3. Duration of lag of regrowth of E. coli and S. aureus due to exposure to the single and combination of ciprofloxacin (CIP) 
and sesquiterpenoids (GE - Germacrene D; GU - Guaiazulene; NL - Nerolidol)
Duration of Lag of Regrowth (h) 
E. coli S. aureus 
CIP 1.75 0.15 
GE 0.33 -0.2 
GU 0 -0.6 
NL 0.5 > 7 
CIP/GE 2.7 1.9 
CIP/GU 2.0 -1.3 
CIP/NL 2.5 > 7 
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 NL moderately decreased the culturability of E. coli. This 
effect was also observed when in combination with CIP (P > 
0.05). NL decreased significantly the culturability of S. 
aureus (Fig. 2d). However, in combination with CIP, NL 
antimicrobial effect on S. aureus was reduced by 2 log CFU 
(P < 0.05). 
 Due to the sesquiterpenoids inherent lipophilicity proper-
ties, they show an affinity to interact with biological mem-
branes, where their accumulation may cause substantial im-
pacts at structural and functional levels [11]. In order to clar-
ify this issue, sesquiterpenoids and/or CIP effect was ascer-
tained through PI uptake determination (Fig. 3). The PI in-
ability to penetrate cells with intact outer membranes was 
confirmed by the low level of uptake observed in bacteria 
not exposed to either CIP or sesquiterpenoids (results not 
shown). According to Fig. (3a), CIP was able to damage the 
outer layers of E. coli and S. aureus. Two hours of cell expo-
sure to antibiotic, about 70% of the total population was PI 
stained. This effect was time dependent for both species (P < 
0.05), being the ratio of E. coli stained cells higher for lower 
exposure times, in comparison to S. aureus. In fact, the pro-
portion of E. coli and S. aureus stained cells was not equiva-
lent (P < 0.05), except for prolonged exposure times (2 h). 
 GE seems to act on the outer layers of S. aureus and E.
coli, as proposed by Fig. (3b). Its interaction with S. aureus
was prompt, as 15 % of the bacterial population was stained 
with PI, immediately after contact with the chemical. The 
number of PI stained cells was invariable for the several 
sampling times (P > 0.05). Concerning E. coli, GE had a 
more marked effect on its cellular outer layers than on S. 
aureus, this effect being strongly time dependent (P < 0.05). 
For an exposure time of 2 h, the number of PI stained cells 
was more than 75 % of the total population. The combination 
of GE with antibiotic increased the number of S. aureus PI 
stained cells, in comparison with CIP absence (P < 0.05). 
Once more, the number of PI stained cells remained constant 
(P > 0.05). An E. coli conflicting antimicrobial effect was 
found by applying a CIP/GE combination (P < 0.05), in 
comparison to antibiotic absence.  
 Fig (3c) shows that GU at 20 mM did not promote S. 
aureus outer layers disturbance, for any sampling time, pro-
moting only a modest damage on the E. coli population, for 
sampling times of 60, 90 and 120 min, being the proportion 
of E. coli stained cells always smaller than 20 %. The CIP/ 
GU action against E. coli resulted in comparable results with 
CIP absence (P > 0.05). On the contrary, a CIP/GU combi-
nation promoted an extreme effect against S. aureus, for 
sampling times over 60 min, as the entire population pre-
sented outer layer damages. For sampling times of 0 and 30 
min no cells were PI stained.  
 The results of NL applied independently, or in combina-
tion with CIP, (Fig. 3d) show how it strongly interacts with 
S. aureus outer layers as, at 30 min of sampling time, all the 
population was PI stained. The presence of CIP decreased 
the number of PI stained cells for all sampling times, a statis-
tically significant event (P < 0.05). NL also damaged E. coli
outer layers, a phenomenon not time-dependent (P > 0.05). 
The presence of CIP increased the percentage of E. coli
Fig. (2). Antimicrobial effect of 1/5 of the MIC value of ciprofloxacin (a) with 20 mM of germacrene D (b), guaiazulene (c) and nerolidol (d) 
against E. coli and S. aureus at 37 ºC in neutral phosphate buffer. The means ± SD for at least three replicates are illustrated. 
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stained cells which, furthermore, increased with time (P < 
0.05). 
 The decrease on the total bacterial counts number was 
not directly correlated with the PI uptake results (Fig. 4), 
being found for all cases a correlation factor smaller than 0.85. 
The highest correlation obtained was for NL (R2 = 0.839), 
when applied to S. aureus. Poor correlation factors (below 
0.5) were found for GU, when applied to both bacteria, and 
for the combination of CIP/GU against S. aureus (Fig. 4). 
GU seems to prevent CIP from being uptaken by cells. 
DISCUSSION 
 In a chemotherapeutic context, the aim of any antibacte-
rial treatment is to maximize the positive effects (such as 
microbial inactivation, killing) during the period in which 
active levels of chemical are present, and to minimize the 
negative effects (such as microbial regrowth, induction of 
resistant phenotypes) when in presence of sub-inhibitory 
chemical concentrations [20]. Due to the increased bacterial 
resistance to conventional antibiotics, new strategies need to 
be developed. In this context, plants secondary metabolites 
demonstrate potential to act as antimicrobials, or synergists 
for other compounds [11,14]. It is known that terpenoids by 
themselves may exert some antimicrobial activity. Previous 
studies [11,15,16,22,23] already described the antimicrobial 
potential of these plant secondary metabolites. 
 In this study, the antimicrobial efficacy of four antibiotics 
representing drug families of major clinical importance, 
aminoglycoside (GEN), fluoroquinolone (CIP), glycopeptides 
(VAN) and macrolide (ERY) were tested, alone or in combi-
nation with three samples of sesquiterpenoids (Fig. 1), 
against E. coli and S. aureus. The GU is composed by two 
unsaturated ring structures which confer rigidity and hydro-
phobicity to its molecular structure; and NL is composed by 
a linear structure containing one hydroxyl group that confers 
molecular flexibility and polarity to one part of the backbone 
chain. The GE molecular structure is composed by a 10 car-
bon ring containing two double bonds that confers hydro-
phobicity and semi-rigidity to the molecule. It is important to 
Fig. (3). Permeability of ciprofloxacin (1/5 MIC) treated E. coli and S. aureus (a) to propidium iodide (PI) when in combination with ger-
macrene D (GE) (b), guaiazulene (GU) (c) and nerolidol (NL) (d). The means ± SD for at least three replicates are illustrated. 
Fig. (4). Correlation factor between loss of culturability and cellular 
permeability to PI for E. coli and S. aureus.
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point out that the GE enriched extract also contains other 
sesquiterpenoids, namely the -farnesene that is composed 
by a linear structure containing one hydroxyl group that con-
fers molecular flexibility and polarity to one part of the 
backbone chain (Fig. 1). The effects observed with this natu-
ral extract may not be explained only by the presence of GE. 
This study reinforces the positive effects of the combination 
of some natural derived compounds with standard antimicro-
bial agents to improve the efficacy of antibacterial treat-
ments. 
 Antimicrobial activity testing by disc diffusion assay, 
revealed the increase of activity for the several antibiotics 
applied to inhibit S. aureus growth, in the presence of GU 
and NL (except for ERY), and also for GE when in the pres-
ence of ERY and VAN. E. coli was insusceptible to the pres-
ence of sesquiterpenoids, as assessed by disc diffusion assay. 
This result is not corroborated by MIC assays, as the pres-
ence of sesquiterpenoids always decreased the MIC value of 
CIP, ERY and GEN, when applied to E. coli. This reinforces 
the advantageous antimicrobial effect of sesquiterpenoids 
combination with antibiotics, an effect related with the in-
crease of antibiotic bacterial sensitivity. A similar effect was 
also described by Brehm-Stechter and Johnson [11], for NL. 
The combination of sesquiterpenoids with VAN revealed an 
undesirable antimicrobial effect against E. coli. Such a phe-
nomenon is probably related with chemical interactions, 
which lead to an increase in the E. coli growth potential. In 
fact, VAN is known to inhibit the cell wall synthesis of 
Gram-positive bacteria, being inactive against Gram-negative 
[6]. E. coli was, with the exception of CIP (MIC for S. 
aureus > MIC E. coli), generally less susceptible to the anti-
biotics comparatively to S. aureus, as its outer membrane 
constitutes a stronger barrier to antibiotic entry [3]. In Gram-
negative bacteria, an outer membrane and a set of multi-drug 
resistance pumps are quite effective barriers for antimicro-
bial compounds [14,24]. Gram-positive bacteria possess a 
permeable cell wall that usually does not restrict the penetra-
tion of antimicrobials [25]. Furthermore, the processes in-
volved in the antimicrobial action comprise transportation of 
the antimicrobial agent to the surface of the cell, adsorption, 
diffusion, penetration and interaction at the target site. These 
processes are not instantaneous, and the time they take to 
fully occur, and the correspondent killing time, may differ 
within antimicrobial agents. The differences also depend on 
its mode of action, as well as on the chemical constitution 
and the antimicrobials chemical-physical properties [26]. 
 PAE studies constitute important data providers for effi-
cient chemotherapeutic strategies implementation. Such 
studies showed that GE extract and NL increased moderately 
the E. coli lag of regrowth, while only NL significantly in-
creased the S. aureus lag. PAE values are important as 
pharmacodynamic predictors [20], allowing the assessment 
of an antimicrobial agent impact on a target microorganism. 
Appropriate antibiotic dose is the key to infection-causing 
bacteria eradication, and an important factor in the emer-
gence and proliferation of antibiotic-resistant strains. A com-
bined treatment CIP/sesquiterpenoid, lead to a prolonged lag 
of regrowth, for both bacteria and all situations, except in the 
presence of GU for S. aureus. In this particular situation, the 
potential of regrowth increased significantly (1.3 h).  
 Time-kill assays demonstrate a significant antibacterial 
effect of GE and NL against S. aureus, together with a mod-
est effect against E. coli. Increased uptake of the nucleic acid 
stain PI, to which cell membrane is normally impermeable, 
was observed, revealing cell permeabilization. The PI results 
demonstrated marked interactions with bacterial outer layers, 
by a single application of CIP (both bacteria), GE (E. coli), 
GU (S. aureus) and NL (both bacteria). However, Fig. (4)
shows that bacterial viability (Fig. 2) was not only associated 
with cellular permeabilization (Fig. 3). This result leads to 
speculate that other cellular targets, critical for cell survival, 
can be behind the mechanism of action of the distinct ses-
quiterpenoids. On a previous study [11], NL was found to 
cause the rapid and non-specific uptake of exogenous com-
pounds, such as antibiotics, by both Gram-negative and -
positive bacteria. CIP exerts its antimicrobial action by inter-
fering with DNA synthesis. Its mode of action depends upon 
the blockage of bacterial DNA replication, by binding itself 
to a DNA gyrase, thereby causing double-stranded breaks  
in the bacterial chromosome [27]. Fluoroquinolones uptake 
occurs by simple diffusion [28], and a sesquiterpenoids dam-
aged bacterial outer layer allows an increased antibiotic 
antimicrobial action. However, the sesquiterpenoids mole-
cular properties can account for only part of the antimicro-
bial properties, probably acting as a multi-target agent, 
enabling the prediction and observation of specific sesquiter-
penoid/microorganisms interactions. 
 The overall results show that GE extract and NL are 
promising chemicals for antimicrobial treatments, enhancing 
antimicrobial activity and pharmacodynamic parameters of 
conventional antibiotics. As sesquiterpenoids are lipophilic 
chemicals, sensitizing bacterial outer layers [11,16], they can 
also act by avoiding active efflux mechanism of resistance. 
Furthermore, these substances seem to be adjuvant agents for 
fighting multi-drug resistant microorganisms.  
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